Detalhe da pesquisa
1.
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med
; 387(7): 599-610, 2022 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36070710
2.
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
Clin Infect Dis
; 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38690892
3.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial.
Clin Infect Dis
; 76(3): e1-e9, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36124697
4.
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2.
J Clin Transl Sci
; 7(1): e242, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38033705
5.
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Lancet Infect Dis
; 23(10): 1119-1129, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37302406
6.
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial.
medRxiv
; 2023 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37333243
7.
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms.
Open Forum Infect Dis
; 9(5): ofac066, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35392460